News

Royce Micro-Cap Trust: Investment Insights and Performance Update

Royce Micro-Cap Trust: Investment Insights and Performance Update

Royce Micro-Cap Trust Investment Overview

Royce Micro-Cap Trust, Inc., a diversified investment company, has been making waves in the investment arena. The fund primarily focuses on long-term capital growth by investing in equity securities of micro-cap companies, those with market capitalizations of $1 billion or less. Currently, Royce Micro-Cap Trust's shares are traded on the New York Stock Exchange under the ticker symbol RMT.

Trading Volume and Investment Experience

The fund has reported an average weekly trading volume of about 355,643 shares, showcasing its active engagement in the market. With more than 50 years of experience in small- and micro-cap investing, Royce Micro-Cap Trust is positioned to capitalize on opportunities in this specialized sector.

Performance Metrics

As of the latest assessment, the net asset value (NAV) of Royce Micro-Cap Trust stands at $10.60, with the market price recorded at $9.32. Investors can look at the performance over different time frames to gauge the potential of the fund's strategy. For instance, the one-month return is reported at -2.21% for NAV and -3.02% for market price. However, the year-to-date performance is encouraging, showing an increase of 7.17% for NAV and 6.77% in market price.

Annual Returns Overview

Reviewing longer-term returns, the fund has shown a one-year return of 28.75% for NAV compared to 29.44% for market price. Additionally, three-year returns average 0.88% for NAV and 1.20% for market price. Over five years, the performance is noted at 12.35% for NAV, showing the fund's resilience and ability to deliver growth over longer durations.

Portfolio Diagnostics

The average market cap of portfolio holdings is reported at approximately $777.4 million, with a weighted average price-to-book (P/B) ratio of 2.0x. As of now, the fund's net assets total around $542 million, emphasizing its robust portfolio structure. The P/B ratio, calculated by dividing a company's share price by its book value per share, can provide insights into the fair value of investments held.

Top Holdings and Sector Allocations

Royce Micro-Cap Trust features a diverse range of investments. The top ten positions in the portfolio include Sprott at 2.1%, PAR Technology at 1.9%, and Transcat at 1.8%. Each of these companies represents significant opportunities within the micro-cap investment segment.

Sector Distribution

The fund's sector allocation reveals a strong focus on Information Technology, which comprises 23.8% of net assets, followed closely by Industrials at 22.8%. Other sectors like Financials (15.7%), Health Care (11.4%), and Materials (6.0%) also highlight diverse exposure aimed at mitigating risks and capturing growth across various market segments.

Recent Developments and Resources

In recent developments, Royce Micro-Cap Trust continues to provide its investors with updated daily NAVs, accessible through various ticker symbol lookup services. This proactive transparency ensures that investors can make informed decisions based on the most current information.

To learn more about the fund's strategic goals, associated risks, fees, and investment horizons, it is essential for investors to conduct their due diligence. Interested individuals should consider all details thoroughly before committing to an investment in Royce Micro-Cap Trust.

Frequently Asked Questions

What is the investment focus of Royce Micro-Cap Trust?

The fund primarily targets long-term capital growth by investing in micro-cap companies with market capitalizations of $1 billion or less.

How can I find the daily NAV for Royce Micro-Cap Trust?

Investors can find daily NAVs on the fund's website and through various financial platforms that track ticker symbols.

What are the top sectors represented in the fund?

The top sectors in Royce Micro-Cap Trust include Information Technology, Industrials, and Financials, among others.

How does the portfolio's performance measure over time?

Portfolio performance varies, but the fund has demonstrated significant growth over the past year and longer periods, which is outlined in their performance metrics.

Is there a risk involved in investing in micro-cap companies?

Yes, investing in micro-cap companies carries more risk than larger companies. The diversified portfolio of Royce Micro-Cap Trust aims to manage this risk while seeking growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Chicken Salad Chick Expands in Texas with New Opening

Updated Category News Views 82

A New Flavor in Town: Chicken Salad Chick Opens in Texas When you hear about chicken salad, you probably don't think of Texas as its new frontier. But here we are, with Chicken Salad Chick spreading its wings in Victoria County. Come November 18, the folks down there will be in for a treat with the grand opening of the nation’s only fast casual chicken salad restaurant...

Continue Reading
Pollo Campero's Care Cups Aid St. Jude's Mission

Updated Category News Views 32

Pollo Campero’s Charitable Tradition Continues You know, in a world where headlines scream for attention, it's refreshing to see Pollo Campero sticking to their guns by backing St. Jude Children's Research Hospital. For eight solid years, this fried chicken champion has been dishing out more than just crispy delights; they're serving up hope, one cup at a time. Every...

Continue Reading
Surgical Planning Associates Expands HipInsight Options

Updated Category News Views 108

A Broader Horizon for Hip Surgery Planning Well, here we go—a medical technology play that's actually stirring things up, and not just blowing smoke. Surgical Planning Associates (SPA)—a name you might wanna keep an eye on—is turning heads with their HipInsight System. Just this week, they let it be known they've added five more implant systems to their 3D...

Continue Reading
Moberg Pharma Secures U.S. Patent for MOB-015 Innovation

Updated Category News Views 166

Moberg Pharma's Fresh U.S. Patent: A Game Changer? Moberg Pharma just snagged a U.S. patent for their whiz-bang dosing of MOB-015. Yup, the FDA’s go-ahead is still out of reach, but this patent is like hitting a full house on the river—sweetening the pot significantly. It's all about onychomycosis, or nail fungus, if you're not up on your medical terms. With patent...

Continue Reading
UN Forum Unleashes LatAm CEO Coalition for Action

Updated Category News Views 34

Latin America Takes Center Stage When the UN turns its spotlight on a region, you know there's something afoot. Right in Montevideo, Uruguay, the United Nations Global Compact gathered a hefty crowd of over 300 leaders from diverse backgrounds—think business, finance, government, and academia. What they were brewing wasn’t just talk; it was about driving real change...

Continue Reading
Protalix to Reveal Q3 2026 Results Amid Rare Disease Push

Updated Category News Views 49

Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...

Continue Reading
Wincomm & Portwell Unveil Medical AI Tech at MEDICA 2026

Updated Category News Views 125

MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...

Continue Reading
Seaboard's Q3 Financials: A Mixed Bag for Investors

Updated Category News Views 38

Eyeing Seaboard's Earnings: What's the Deal? Seaboard Corporation just dropped its earnings report for the third quarter, and boy, it's a doozy. The numbers show a mixed bag—like finding out your favorite team won, but your best player got benched with an injury. On the surface, we've got a rise in net sales, but dig a little deeper, and the cracks start to show. Sales...

Continue Reading
Duni AB's 2027 AGM: Strategic Moves Amid Challenges

Updated Category News Views 36

Navigating Choppy Waters: Duni's Market Stance Ever have one of those days when the market just refuses to cooperate no matter how much you hustle? Duni AB knows the feeling all too well. As this Swedish outfit gears up for its 2027 AGM, they're grinding through an array of challenges as prickly as a porcupine. Here's the scoop: their interim report from earlier this year...

Continue Reading
Sesame Software's Game-Changer: Smooth CRM Switch

Updated Category News Views 80

Why Leaving Salesforce Isn't as Crazy as It Sounds Stepping away from Salesforce isn't your run-of-the-mill decision for businesses. It’s more like abandoning ship, anticipating lurking dangers: losing cherished data, facing burdensome API restrictions, and fretting over years of trapped history. It’s not as simple as flipping a switch, and that’s what keeps most...

Continue Reading

Top 5 Most Recently Viewed Articles

Eli Lilly Boosts Infectious Disease Strategy in 2026

Updated Category News Views 31

What's Eli Lilly Cooking Up? So, Eli Lilly is throwing some serious chips on the table with these new acquisitions. The pharma giant is snapping up not one, not two, but three companies—all to bolster its infectious disease game. Now, if you've been around the market block as long as I have, you know they aren't just doing this for fun. It's about strategic positioning,...

Continue Reading
Equip Expo Shines Bright as Top Finalist in Multiple Awards

Updated Category News Views 270

Equip Exposition Acknowledged as a Top Trade Show Finalist Recently, Equip Exposition has garnered notable attention as it was recognized as a finalist in four categories by Trade Show Executive's Gold 100 Grand Awards. This prestigious event showcases top trade shows across the nation, and Equip Exposition is proudly positioned among the best in the industry....

Continue Reading
Homestyler Reinvents Interior Design with Innovative 3D Toolset

Updated Category News Views 325

Homestyler Launches Revolutionary Design Tools During their remarkable showcase at a recent market event, Homestyler introduced cutting-edge 3D cloud design tools, alongside a new Global Partner Program. Aimed at home decorators, interior designers, and enthusiasts, these innovations are set to streamline the design process and enhance the creative experience for users....

Continue Reading
DunhamTrimmer Unveils In-Depth Report on Fertilizer Market Trends

Updated Category News Views 360

DunhamTrimmer's Latest Insights into the Fertilizer Market DunhamTrimmer has announced the release of their comprehensive 2024 Global Value-Added Fertilizer Market Report. This detailed report, comprising over 500 pages, sheds light on the rapidly evolving global value-added fertilizer (VAF) industry, which is estimated to approach a remarkable $20 billion. As the leading...

Continue Reading
Lipocine Reports Q3 Financial Results and Future Outlook

Updated Category News Views 125

Lipocine Financial Overview for Q3 Lipocine Inc. (NASDAQ: LPCN) is a biopharmaceutical company known for its innovative oral delivery technologies. Recently, they provided a detailed update on their financial results for the third quarter ended September 30, 2025. The report highlighted not only their financial performance but also significant advancements in their...

Continue Reading